BACKGROUND: Previous investigations have revealed that Mycobacterium ulcerans is extensively distributed spatially throughout ulcerative lesions, including in the margins of excised tissue. In contrast, bacilli in pre-ulcerative lesions are assumed to be concentrated in the center of the lesion. In order to assess the extent to which the surgical excision of pre-ulcerative lesions is capable of removing all infected tissue, we subjected the excision margins of pre-ulcerative lesions to laboratory analysis. PATIENTS AND METHODS: Eleven patients with laboratory-confirmed pre-ulcerative lesions were included in the study. The diameter of the lesion and excised tissue and the "surgical distance" between the border of the lesion and excision margin were measured. The entire excision margin was cut into segments and subjected to IS2404 PCR. RESULTS: The results from the PCR analysis on the samples of excision margins were highly significantly associated with the surgical distance (p < 0.001). The margin samples of nodules were significantly more often PCR positive than the plaques (p = 0.025). The size of the lesion and the size of the excised tissue did not significantly influence the PCR results. Statistically, a surgical distance of more than 9 mm was found to reduce the risk of remaining infected tissue to less than 10%, that of 13 mm to reduce the risk to less than 5%, and that of 25 mm to reduce the risk to nearly 0%. CONCLUSION: The results of this study show that in preulcerative Buruli ulcer disease, bacilli may extend beyond the actual size of the lesion and that there is a strong correlation between the presence of M. ulcerans in the margin samples and the surgical distance. Excision with a surgical distance of 25 mm avoided the risk of remaining mycobacteria in this study. However, no recurrences occurred in the patients with M. ulcerans-positive excision margins. The need of postoperative antimycobacterial treatment in these patients remains to be determined.
BACKGROUND: Previous investigations have revealed that Mycobacterium ulcerans is extensively distributed spatially throughout ulcerative lesions, including in the margins of excised tissue. In contrast, bacilli in pre-ulcerative lesions are assumed to be concentrated in the center of the lesion. In order to assess the extent to which the surgical excision of pre-ulcerative lesions is capable of removing all infected tissue, we subjected the excision margins of pre-ulcerative lesions to laboratory analysis. PATIENTS AND METHODS: Eleven patients with laboratory-confirmed pre-ulcerative lesions were included in the study. The diameter of the lesion and excised tissue and the "surgical distance" between the border of the lesion and excision margin were measured. The entire excision margin was cut into segments and subjected to IS2404 PCR. RESULTS: The results from the PCR analysis on the samples of excision margins were highly significantly associated with the surgical distance (p < 0.001). The margin samples of nodules were significantly more often PCR positive than the plaques (p = 0.025). The size of the lesion and the size of the excised tissue did not significantly influence the PCR results. Statistically, a surgical distance of more than 9 mm was found to reduce the risk of remaining infected tissue to less than 10%, that of 13 mm to reduce the risk to less than 5%, and that of 25 mm to reduce the risk to nearly 0%. CONCLUSION: The results of this study show that in preulcerative Buruli ulcer disease, bacilli may extend beyond the actual size of the lesion and that there is a strong correlation between the presence of M. ulcerans in the margin samples and the surgical distance. Excision with a surgical distance of 25 mm avoided the risk of remaining mycobacteria in this study. However, no recurrences occurred in the patients with M. ulcerans-positive excision margins. The need of postoperative antimycobacterial treatment in these patients remains to be determined.
Authors: G Bretzel; V Siegmund; J Nitschke; K H Herbinger; W Thompson; E Klutse; K Crofts; W Massavon; S Etuaful; R Thompson; K Asamoah-Opare; P Racz; F Vloten; C van Berberich; T Kruppa; E Ampadu; B Fleischer; O Adjei Journal: Trop Med Int Health Date: 2007-01 Impact factor: 2.622
Authors: Daniel P O'Brien; Andrew J Hughes; Allen C Cheng; Margaret J Henry; Peter Callan; Anthony McDonald; Ian Holten; Mike Birrell; John M Sowerby; Paul D R Johnson; Eugene Athan Journal: Med J Aust Date: 2007-01-15 Impact factor: 7.738
Authors: Laura Chin-Lenn; David Ying; James Leong; David Ross; Terry Wu; Simon Nazaretian; Simon Donahoe; Ram Silfen Journal: Ann Plast Surg Date: 2006-07 Impact factor: 1.539
Authors: S Etuaful; B Carbonnelle; J Grosset; S Lucas; C Horsfield; R Phillips; M Evans; D Ofori-Adjei; E Klustse; J Owusu-Boateng; G K Amedofu; P Awuah; E Ampadu; G Amofah; K Asiedu; M Wansbrough-Jones Journal: Antimicrob Agents Chemother Date: 2005-08 Impact factor: 5.191
Authors: T Stinear; B C Ross; J K Davies; L Marino; R M Robins-Browne; F Oppedisano; A Sievers; P D Johnson Journal: J Clin Microbiol Date: 1999-04 Impact factor: 5.948
Authors: G Bretzel; V Siegmund; P Racz; F van Vloten; F Ngos; W Thompson; P Biason; O Adjei; B Fleischer; J Nitschke Journal: Trop Med Int Health Date: 2005-11 Impact factor: 2.622
Authors: Kirstie M Mangas; Nicholas J Tobias; Estelle Marion; Jérémie Babonneau; Laurent Marsollier; Jessica L Porter; Sacha J Pidot; Chinn Yi Wong; David C Jackson; Brendon Y Chua; Timothy P Stinear Journal: PeerJ Date: 2020-08-07 Impact factor: 2.984
Authors: Alexandra G Fraga; Teresa G Martins; Egídio Torrado; Kris Huygen; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa Journal: PLoS One Date: 2012-03-08 Impact factor: 3.240